HYPROMELLOSE 2910 (15 MPA.S)

Substance profile for UNII 36SFW2JZ0W, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
36SFW2JZ0W
Preferred term
HYPROMELLOSE 2910 (15 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300450
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300450mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300450
FDA Substance Registration System36SFW2JZ0Wprecision.fda.gov/uniisearch/srs/unii/36SFW2JZ0W

DailyMed Socrata Ingredients#

Ingredient, DailyMed label, SPL version table
IngredientDailyMed labelSPL version
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN1
HYPROMELLOSE 2910 (15 MPA.S)DOCUSATE SODIUM AND SENNA2
HYPROMELLOSE 2910 (15 MPA.S)NeuroBion Tablets1
HYPROMELLOSE 2910 (15 MPA.S)NeuroBion Tablets1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use azithromycin tablets safely and effectively. See full prescribing information for azithromycin tablets . AZITHROMYCIN tablets USP for oral use Initial U.S. Approval: 19911
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Tacrolimus Capsules USP safely and effectively. See full prescribing information for Tacrolimus Capsules USP. Tacrolimus Capsules USP Initial U.S. Approval 1994 Rx Only9
HYPROMELLOSE 2910 (15 MPA.S)AMOXICILLIN - amoxicillin tablet, film coated1
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN MONOHYDRATE5
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Irbesartan and Hydrochlorothiazide Tablets USP safely and effectively. See full prescribing information for Irbesartan and Hydrochlorothiazide Tablets USP. Irbesartan and Hydrochlorothiazide Tablets, USP Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20023
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19974
HYPROMELLOSE 2910 (15 MPA.S)Rx only2
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use esomeprazole magnesium delayed-release capsules USP safely and effectively. See full prescribing information for esomeprazole magnesium delayed-release capsules USP. ESOMEPRAZOLE MAGNESIUM delayed-release capsules USP, for oral use Initial U.S. Approval: 1989 (omeprazole)2
HYPROMELLOSE 2910 (15 MPA.S)Metformin Hydrochloride Tablets USP1
HYPROMELLOSE 2910 (15 MPA.S)GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only5
HYPROMELLOSE 2910 (15 MPA.S)48347e88-ce20-4b44-9f72-0282b0e653a01
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP. DIVALPROEX sodium delayed-release tablets, USP for oral use Initial U.S. Approval: 19831
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. Clopidogrel Tablets USP for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (15 MPA.S)a9bdb9b3-51fb-453d-9961-3babdf4b65451
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001001
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19974
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use donepezil hydrochloride tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets USP. DONEPEZIL hydrochloride tablets USP for oral use Initial U.S. Approval: 19961000
HYPROMELLOSE 2910 (15 MPA.S)BuPROPion Hydrochloride Tablets, USP3
HYPROMELLOSE 2910 (15 MPA.S)BuPROPion Hydrochloride Tablets, USP3
HYPROMELLOSE 2910 (15 MPA.S)b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea3
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Escitalopram Tablets USP safely and effectively. See full prescribing information for Escitalopram Tablets USP. Initial U.S. Approval: 20025
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20001
HYPROMELLOSE 2910 (15 MPA.S)e043f9fe-8cbd-44f7-b8c1-fd8c5e4478f31
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE TABLETS, USP safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE TABLETS, USP. Bupropion Hydrochloride Tablets, USP for oral use Initial U.S. Approval: 19852
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use donepezil hydrochloride tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets USP. DONEPEZIL hydrochloride tablets USP for oral use Initial U.S. Approval: 19961
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. CLOPIDOGREL Tablets USP, for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (15 MPA.S)BuPROPion Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS1
HYPROMELLOSE 2910 (15 MPA.S)FACTIVE ® (gemifloxacin mesylate) Tablets1
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel bisulfate safely and effectively. See full prescribing information for clopidogrel tablets, USP. Clopidogrel Tablets, USP Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (15 MPA.S)Acetaminophen Extra Strength 500 mg1
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS2
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use amoxicillin tablets safely and effectively. See full prescribing information for amoxicillin tablets, USP. Amoxicillin Tablets, USP Initial U.S. Approval: 1974 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use dicyclomine hydrochloride safely and effectively. See full prescribing information for dicyclomine hydrochloride . Dicyclomine hydrochloride capsules, for oral use Dicyclomine hydrochloride tablets, for oral use Initial U.S. Approval: 19502
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (15 MPA.S)Aspirin NSAIDS EC Tablet 325mg- 5gr9
HYPROMELLOSE 2910 (15 MPA.S)Azithromycin Tablets USP, 250 mg and 500 mg 7146 7169 Rx only1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use Renagel safely and effectively. See full prescribing information for Renagel. Renagel (sevelamer hydrochloride) Tablet for Oral use Initial U.S. Approval: 20003
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19952
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel safely and effectively. See full prescribing information for clopidogrel. Clopidogrel Tablets, USP Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19974
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use alfuzosin HCl extended-release tablets safely and effectively. See full prescribing information for alfuzosin HCl extended-release tablets. Alfuzosin Hydrochloride Extended-Release Tablets Initial U.S. Approval: 20031
HYPROMELLOSE 2910 (15 MPA.S)PREMARIN ® (conjugated estrogens tablets, USP)1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19971
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS1
HYPROMELLOSE 2910 (15 MPA.S)70010341 Dicyclomine HCl Capsules USP Dicyclomine HCl Tablets USP Revised: May 2003 Rx only1
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN TABLETS USP, 250 mg and 500 mg 7146 7169 Rx only1
HYPROMELLOSE 2910 (15 MPA.S)be65d31a-87c1-4f37-a55d-7395bfe3642a2
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS1
HYPROMELLOSE 2910 (15 MPA.S)DRUG FACTS1
HYPROMELLOSE 2910 (15 MPA.S)BuPROPion Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (15 MPA.S)Appbutamone5
HYPROMELLOSE 2910 (15 MPA.S)Appbutamone-D12
HYPROMELLOSE 2910 (15 MPA.S)These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezil Hydrochloride Tablets,5 mg and 10 mg Initial U.S. Approval: 19965
HYPROMELLOSE 2910 (15 MPA.S)Amoxicillin Tablets, USP2
HYPROMELLOSE 2910 (15 MPA.S)efb195b9-b995-48f3-a4cb-b7e09d56350e2
HYPROMELLOSE 2910 (15 MPA.S)Pravastatin Sodium1
HYPROMELLOSE 2910 (15 MPA.S)Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension Sterile1
HYPROMELLOSE 2910 (15 MPA.S)BuPROPion Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (15 CPS)PREMARIN ® (conjugated estrogens tablets, USP)1
HYPROMELLOSE 2910 (15 CPS)BuPROPion Hydrochloride Tablets, USP1
HYPROMELLOSE 2910 (15 CPS)Bupropion2
HYPROMELLOSE 2910 (15 CPS)Drug Facts1
HYPROMELLOSE 2910 (15 CPS)These highlights do not include all the information needed to use AVALIDE safely and effectively. See full prescribing information for AVALIDE. AVALIDE (irbesartan and hydrochlorothiazide) tablet for oral use AVALIDE (irbesartan and hydrochlorothiazide) tablet, film coated for oral use Initial U.S. Approval: 19972
HYPROMELLOSE 2910 (15 CPS)c83616c9-c222-4e3e-91bd-c7839406bb2a1
HYPROMELLOSE 2910 (15 MPA.S)BUPROPION HYDROCHLORIDE TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3955
HYPROMELLOSE 2910 (15 MPA.S)PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3692
HYPROMELLOSE 2910 (15 MPA.S)PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3690
HYPROMELLOSE 2910 (15 MPA.S)DICYCLOMINE HYDROCHLORIDE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3221
HYPROMELLOSE 2910 (15 MPA.S)BUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
HYPROMELLOSE 2910 (15 MPA.S)ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1002
HYPROMELLOSE 2910 (15 MPA.S)CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (15 MPA.S)ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2910 (15 MPA.S)BUPROPION HYDROCHLORIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (15 MPA.S)DOCUSATE SODIUM AND SENNA (DOCUSATE SODIUM AND SENNA ) TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (15 MPA.S)ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (15 MPA.S)TACROLIMUS CAPSULE, GELATIN COATED [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2910 (15 MPA.S)PREMPHASE (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) KIT PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]22
HYPROMELLOSE 2910 (15 MPA.S)MORPHINE SULFATE TABLET, EXTENDED RELEASE [QUALITEST PHARMACEUTICALS]21
HYPROMELLOSE 2910 (15 MPA.S)PREMARIN (ESTROGENS, CONJUGATED) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]21
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]20
HYPROMELLOSE 2910 (15 MPA.S)GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]19
HYPROMELLOSE 2910 (15 MPA.S)BUPROPION HYDROCHLORIDE TABLET, FILM COATED [SANDOZ INC]18
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]17
HYPROMELLOSE 2910 (15 MPA.S)BUPROPION HYDROCHLORIDE TABLET, FILM COATED [MAJOR PHARMACEUTICALS]16
HYPROMELLOSE 2910 (15 MPA.S)DIVALPROEX SODIUM TABLET, DELAYED RELEASE [AUROBINDO PHARMA LIMITED]16
HYPROMELLOSE 2910 (15 MPA.S)DICYCLOMINE HYDROCHLORIDE CAPSULE DICYCLOMINE HYDROCHLORIDE TABLET [ACTAVIS PHARMA, INC.]15
HYPROMELLOSE 2910 (15 MPA.S)DICYCLOMINE HYDROCHLORIDE TABLET [PD-RX PHARMACEUTICALS, INC.]15
HYPROMELLOSE 2910 (15 MPA.S)DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]15
HYPROMELLOSE 2910 (15 MPA.S)FAMCICLOVIR TABLET, FILM COATED [ACTAVIS PHARMA, INC.]14
HYPROMELLOSE 2910 (15 MPA.S)ZOLPIDEM TARTRATE TABLET, COATED [SANDOZ INC]14
HYPROMELLOSE 2910 (15 MPA.S)DILTIAZEM HYDROCHLORIDE TABLET, EXTENDED RELEASE [WATSON PHARMA, INC.]13
HYPROMELLOSE 2910 (15 MPA.S)RENAGEL TABLET [GENZYME CORPORATION]13
HYPROMELLOSE 2910 (15 MPA.S)RENVELA (SEVELAMER CARBONATE) TABLET, FILM COATED RENVELA (SEVELAMER CARBONATE) POWDER, FOR SUSPENSION [GENZYME CORPORATION]13
HYPROMELLOSE 2910 (15 MPA.S)ESCITALOPRAM TABLET, FILM COATED [INTERNATIONAL LABS, INC.]12
HYPROMELLOSE 2910 (15 MPA.S)RIBAVIRIN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]12
HYPROMELLOSE 2910 (15 MPA.S)DOXYCYCLINE TABLET [HERITAGE PHARMACEUTICALS INC.]11
HYPROMELLOSE 2910 (15 MPA.S)METFORMIN HYDROCHLORIDE TABLET, FILM COATED [ASCEND LABORATORIES, LLC]11
HYPROMELLOSE 2910 (15 MPA.S)PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]11
HYPROMELLOSE 2910 (15 MPA.S)QUETIAPINE FUMARATE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]11
HYPROMELLOSE 2910 (15 MPA.S)TOPIRAMATE TABLET [TEVA PHARMACEUTICALS USA INC]11
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN TABLET, FILM COATED [PLIVA, INC.]10
HYPROMELLOSE 2910 (15 MPA.S)AZITHROMYCIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]10
HYPROMELLOSE 2910 (15 MPA.S)GEMFIBROZIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]10
HYPROMELLOSE 2910 (15 MPA.S)AMOXICILLIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]9
HYPROMELLOSE 2910 (15 MPA.S)ESCITALOPRAM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]9
HYPROMELLOSE 2910 (15 MPA.S)PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [CARDINAL HEALTH]9
HYPROMELLOSE 2910 (15 MPA.S)AMOXICILLIN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]8
HYPROMELLOSE 2910 (15 MPA.S)CLARITHROMYCIN TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]8

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 36SFW2JZ0W page 1 of 1 · 14 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653SOLUTIONOPHTHALMIC0.5 %w/v
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653CAPSULEORAL70 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653CAPSULE, DELAYED RELEASEORAL129 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653CAPSULE, EXTENDED RELEASEORAL100 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653FILM, SOLUBLEORAL47 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653SUSPENSIONORAL400 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLETORAL360 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLET, DELAYED RELEASEORAL120 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLET, EXTENDED RELEASEORAL748 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLET, FILM COATEDORAL48 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLET, FILM COATED, EXTENDED RELEASEORAL15 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEORAL54 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653FILMSUBLINGUAL7 mg
HYPROMELLOSE 2910 (15 MPA.S)36SFW2JZ0W9004653INSERTVAGINAL105 mg